Drovelis 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification1 
Decision 
Information 
issued on 
Issued2 / 
affected3  
IA/0022/G 
This was an application for a group of variations. 
05/12/2023 
A.7 - Administrative change - Deletion of 
manufacturing sites 
A.7 - Administrative change - Deletion of 
manufacturing sites 
amended 
on 
Annex II and 
PL 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
 
A.7 - Administrative change - Deletion of 
manufacturing sites 
PSUSA/10938
Periodic Safety Update EU Single assessment - 
30/11/2023 
n/a 
PRAC Recommendation - maintenance 
/202305 
drospirenone / estetrol 
PSUSA/10938
Periodic Safety Update EU Single assessment - 
08/06/2023 
n/a 
PRAC Recommendation - maintenance 
/202211 
drospirenone / estetrol 
IB/0018 
C.I.3.z - Change(s) in the SPC, Labelling or PL 
30/03/2023 
SmPC and PL 
intended to implement the outcome of a procedure 
concerning PSUR or PASS or the outcome of the 
assessment done under A 45/46 - Other variation 
IAIN/0019 
B.III.1.a.1 - Submission of a new/updated or 
21/03/2023 
n/a 
deletion of Ph. Eur. Certificate of Suitability to the 
relevant Ph. Eur. Monograph - New certificate from 
an already approved manufacturer 
IB/0016 
C.I.11.z - Introduction of, or change(s) to, the 
03/03/2023 
n/a 
obligations and conditions of a marketing 
authorisation, including the RMP - Other variation 
PSUSA/10938
Periodic Safety Update EU Single assessment - 
01/12/2022 
n/a 
PRAC Recommendation - maintenance 
/202205 
drospirenone / estetrol 
IA/0015/G 
This was an application for a group of variations. 
30/11/2022 
n/a 
B.II.d.2.a - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
Page 2/8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.II.d.2.a - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
IB/0014 
B.II.f.1.b.1 - Stability of FP - Extension of the shelf 
29/11/2022 
n/a 
life of the finished product - As packaged for sale 
(supported by real time data) 
IB/0011/G 
This was an application for a group of variations. 
14/11/2022 
n/a 
B.I.b.1.h - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Addition or 
replacement (excl. Biol. or immunol. substance) of a 
specification parameter as a result of a safety or 
quality issue 
B.I.b.1.d - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Deletion of a non-
significant specification parameter (e.g. deletion of 
an obsolete parameter) 
B.I.a.3.a - Change in batch size (including batch size 
ranges) of AS or intermediate - Up to 10-fold 
increase compared to the originally approved batch 
size 
B.I.a.2.e - Changes in the manufacturing process of 
the AS - Minor change to the restricted part of an 
ASMF 
B.I.a.2.e - Changes in the manufacturing process of 
the AS - Minor change to the restricted part of an 
ASMF 
Page 3/8 
 
 
 
 
 
 
 
 
 
 
 
 
B.I.a.1.i - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - 
Introduction of a new site of micronisation 
B.I.a.1.a - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - The 
proposed manufacturer is part of the same 
pharmaceutical group as the currently approved 
manufacturer 
A.4 - Administrative change - Change in the name 
and/or address of a manufacturer or an ASMF holder 
or supplier of the AS, starting material, reagent or 
intermediate used in the manufacture of the AS or 
manufacturer of a novel excipient 
IB/0012 
B.II.b.3.z - Change in the manufacturing process of 
03/11/2022 
n/a 
the finished or intermediate product - Other variation 
IAIN/0013/G 
This was an application for a group of variations. 
18/10/2022 
n/a 
B.III.1.a.2 - Submission of a new/updated or 
deletion of Ph. Eur. Certificate of Suitability to the 
relevant Ph. Eur. Monograph - Updated certificate 
from an already approved manufacturer 
B.III.1.a.1 - Submission of a new/updated or 
deletion of Ph. Eur. Certificate of Suitability to the 
relevant Ph. Eur. Monograph - New certificate from 
an already approved manufacturer 
B.III.1.a.2 - Submission of a new/updated or 
deletion of Ph. Eur. Certificate of Suitability to the 
relevant Ph. Eur. Monograph - Updated certificate 
from an already approved manufacturer 
Page 4/8 
 
 
 
 
 
 
 
 
 
 
 
 
IA/0009/G 
This was an application for a group of variations. 
25/07/2022 
n/a 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.II.d.2.a - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.II.d.2.a - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
PSUSA/10938
Periodic Safety Update EU Single assessment - 
10/06/2022 
n/a 
PRAC Recommendation - maintenance 
/202111 
drospirenone / estetrol 
IB/0008 
C.I.3.z - Change(s) in the SPC, Labelling or PL 
22/04/2022 
14/10/2022 
SmPC and PL 
Update of Sections 4.4, 4.5 and 4.8 of the SmPC with 
intended to implement the outcome of a procedure 
concerning PSUR or PASS or the outcome of the 
assessment done under A 45/46 - Other variation 
wording based on PRAC recommendation formulated for 
PSUSA (PSUSA/00002182/202101) on 
nomegestrol/estradiol (CMDh meeting held on 12-14 
October 2021). The PL was updated accordingly. 
II/0006/G 
This was an application for a group of variations. 
31/03/2022 
14/10/2022 
Annex II and 
PL 
B.I.a.1.f - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - 
Changes to quality control testing arrangements for 
the AS -replacement or addition of a site where 
batch control/testing takes place 
Page 5/8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.II.b.2.a - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement/addition of a site where batch 
control/testing takes place 
B.II.b.1.z - Replacement or addition of a 
manufacturing site for the FP - Other variation 
II/0004/G 
This was an application for a group of variations. 
16/12/2021 
n/a 
B.II.e.2.c - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Deletion of a non-significant 
specification parameter (e.g. deletion of an obsolete 
parameter) 
B.II.b.1.z - Replacement or addition of a 
manufacturing site for the FP - Other variation 
B.II.d.1.d - Change in the specification parameters 
and/or limits of the finished product - Deletion of a 
non-significant specification parameter 
B.II.d.2.d - Change in test procedure for the finished 
product - Other changes to a test procedure 
(including replacement or addition) 
B.II.d.1.d - Change in the specification parameters 
and/or limits of the finished product - Deletion of a 
non-significant specification parameter 
B.II.e.2.z - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Other variation 
B.II.d.2.d - Change in test procedure for the finished 
product - Other changes to a test procedure 
(including replacement or addition) 
Page 6/8 
 
 
 
 
 
 
 
 
 
B.II.d.1.c - Change in the specification parameters 
and/or limits of the finished product - Addition of a 
new specification parameter to the specification with 
its corresponding test method 
B.II.d.2.d - Change in test procedure for the finished 
product - Other changes to a test procedure 
(including replacement or addition) 
B.II.d.1.z - Change in the specification parameters 
and/or limits of the finished product - Other variation 
B.II.e.2.z - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Other variation 
B.II.d.1.z - Change in the specification parameters 
and/or limits of the finished product - Other variation 
B.II.d.2.d - Change in test procedure for the finished 
product - Other changes to a test procedure 
(including replacement or addition) 
B.II.d.2.d - Change in test procedure for the finished 
product - Other changes to a test procedure 
(including replacement or addition) 
B.II.d.1.c - Change in the specification parameters 
and/or limits of the finished product - Addition of a 
new specification parameter to the specification with 
its corresponding test method 
II/0001/G 
This was an application for a group of variations. 
09/12/2021 
n/a 
B.I.b.1.c - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Addition of a new 
specification parameter to the specification with its 
Page 7/8 
 
 
 
 
 
 
 
 
 
corresponding test method 
B.I.a.1.b - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - 
Introduction of a manufacturer of the AS supported 
by an ASMF 
IAIN/0005 
B.II.b.1.b - Replacement or addition of a 
16/11/2021 
n/a 
manufacturing site for the FP - Primary packaging 
site 
II/0003 
B.I.a.1.b - Change in the manufacturer of AS or of a 
11/11/2021 
n/a 
starting material/reagent/intermediate for AS - 
Introduction of a manufacturer of the AS supported 
by an ASMF 
II/0002 
Update of section 5.3 of the SmPC following a 
30/09/2021 
14/10/2022 
SmPC and PL 
revision of the Environmental Risk Assessment (ERA) 
in order to include the E4 PECsw based on a refined 
Fpen of 0.0044. In addition, the MAH has taken the 
opportunity to implement minor editorial changes in 
the SmPC, Labelling and Package Leaflet. 
C.I.4 - Change(s) in the SPC, Labelling or PL due to 
new quality, preclinical, clinical or pharmacovigilance 
data 
Page 8/8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
